Nano-Cap Biotech Set for Big Moves 🔬

Don’t Sleep on This One…

Good evening, Jeff Bishop here!

This is a wild time for trading, especially small-cap stocks.

Trading legend “Roaring Kitty,” who helped spark the original “meme stock” rally back in 2021, came back to life this week.

His resurgence alone led traders to pile back into old names like AMC and GME, sending the prices to the moon… at least for a few days.

It sparked a renewed wave of frenzied trading in a lot of stocks that most traders had given up on.

Like tiny SLNA, which shot up from $.05 to over $.20 in a matter of days for over a 300% gain, though it came back to Earth on Friday.

The highlight story of the week had to be FFIE, though. 

From under $.10 on Monday to over $3.50 on Friday for a massive 3000%+ move last week.

We haven’t seen gains like that in a long time, and traders are eagerly searching for the next one.

I do want to warn you, though – While these stocks are making fantastic gains, you need to have a good stop-loss strategy in place.

While FFIE hit a high over $3.50 on Friday… on the same day, it came crashing back down under $1 at one point, and I think is likely to head even lower soon.

That’s an incredible single-day loss if you entered at the wrong time and didn’t have a good management plan in place.

Like my new idea on Friday.  While it had a great opportunity early on, it sold off all day long and was a dud.  

Not having a good strategy there would have been painful.

But, there have been so many great trade ideas lately to more than make up for it.

Like the “Bird Flu” stock I told you about a couple of weeks ago when it was trading around $1.70.  It made a new 52-week high both days after I told you about it… and then blasted to $2.50 last week to make another high for the year.

That was nearly 50% of possible gains in a week’s time.

Or just before that, I pointed out one of the strongest small-cap biotech companies this year when it was trading at around $1.80.  

It hit a fresh 52-week high right after that and hasn’t looked back.  That stock hit $2.40 last week for more than 30% possible gains since the alert I sent you.

And that leads me to my next idea tomorrow…

As you know, biotech stocks tend to rise in the weeks and months before major FDA decisions.

A speculative rally in the stock before the decision.

Right now, I'm looking at a low float nano-cap trading under a buck. (You can get first dibs right here tomorrow morning)

Very recently, they announced encouraging preclinical results ...

... with the potential for an IND submission in 2024!

So yes, biotechs can fall 50% in minutes. But they can also move triple-digits in a day when the catalyst is there.

I just showed you several stocks that made insane moves lately, and this one is trading under $1.

The last time I saw it break out (not too long ago), it jumped from about $1.33 - $6.40 in a week!

Are we in the window for it to start running up before the potential 2024 IND submission?

Get the juicy details in the morning.

If you want to be among the FIRST to get this new idea, you’ll need to set a reminder on your phone right now and refresh this page at exactly 9am EST.

If you want to wait for the email, no worries.  I will have that out to you as soon as I can before the market opens. 📬

This is going to be an amazing week once again.  Get ready for it!

To Your Success,

Jeff Bishop

DISCLAIMER: To more fully understand any Ragingbull.com, LLC ("RagingBull") subscription, website, application or other service ("Services"), please review our full disclaimer located at https://ragingbull.com/disclaimer.

FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. Any RagingBull Service offered is for educational and informational purposes only and should NOT be construed as a securities-related offer or solicitation, or be relied upon as personalized investment advice. RagingBull strongly recommends you consult a licensed or registered professional before making any investment decision.

RESULTS PRESENTED NOT TYPICAL OR VERIFIED. RagingBull Services may contain information regarding the historical trading performance of RagingBull owners or employees, and/or testimonials of non-employees depicting profitability that are believed to be true based on the representations of the persons voluntarily providing the testimonial. However, subscribers' trading results have NOT been tracked or verified and past performance is not necessarily indicative of future results, and the results presented in this communication are NOT TYPICAL. Actual results will vary widely given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. Investing in securities is speculative and carries a high degree of risk; you may lose some, all, or possibly more than your original investment.

RAGINGBULL IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Neither RagingBull nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. Employees, owners, and other service providers of RagingBull. com, LLC are paid in whole or in part by commission based on their sales of Services to subscribers.

WE MAY HOLD SECURITIES DISCUSSED. RagingBull has not been paid directly or indirectly by the issuer of any security mentioned in the Services. However, Ragingbull.com, LLC, its owners, and its employees may purchase, sell, or hold long or short positions in securities of the companies mentioned in this communication.